Stroke/Vascular Neurology News

IV thrombolysis appeared safe among patients who had acute ischemic stroke with saccular unruptured intracranial aneurysms, according to results of a prospective cohort study published in Neurology.

Certain ethnic stroke incidence disparities have ended in recent years, according to data from a population-based stroke surveillance study published in Neurology.

Patients who received enzyme-inducing antiseizure medications had increased risk for incident cardiovascular disease, according to results of a cohort study published in JAMA Neurology.

Researchers found no link between telestroke adoption and changes in stroke systems of care in a national sample of hospitals that implemented telestroke practices in EDs, according to a cross-sectional study published in JAMA Network Open.

Blood sugar levels at admission were significantly linked to risk for composite vascular events among patients with ischemic stroke and diabetes, according to results published in Neurology.

Researchers noted a high mortality rate among patients with cerebral venous sinus thrombosis due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination.

Patients with stroke may benefit from more intensive motor rehabilitation at 60 to 90 days after stroke onset, according to results of a phase 2 clinical trial published in Proceedings of the National Academy of Sciences.

Vascular brain injury and cognitive reserve markers were independently associated with cognition, such that higher cognitive reserve did not reduce the adverse effects of covert vascular brain injury.

High maximum systolic BP in the immediate hours following endovascular therapy for ischemic stroke is associated with poor functional outcome and increased risk for symptomatic intracranial hemorrhage, according to data published in Stroke.

Restarting antiplatelet therapy did not significantly increase the risk for recurrent intracerebral hemorrhage or major vascular events, according to a study in JAMA Neurology.